ProPhase Labs Inc (PRPH)
5.15
+0.58
(+12.57%)
USD |
NASDAQ |
May 01, 16:00
5.15
0.00 (0.00%)
After-Hours: 19:23
ProPhase Labs Enterprise Value: 88.08M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 88.08M |
| April 29, 2024 | 88.71M |
| April 26, 2024 | 90.51M |
| April 25, 2024 | 94.85M |
| April 24, 2024 | 96.83M |
| April 23, 2024 | 98.64M |
| April 22, 2024 | 93.94M |
| April 19, 2024 | 100.44M |
| April 18, 2024 | 103.69M |
| April 17, 2024 | 118.67M |
| April 16, 2024 | 138.15M |
| April 15, 2024 | 116.59M |
| April 12, 2024 | 123.18M |
| April 11, 2024 | 121.01M |
| April 10, 2024 | 116.14M |
| April 09, 2024 | 115.60M |
| April 08, 2024 | 124.62M |
| April 05, 2024 | 128.23M |
| April 04, 2024 | 124.26M |
| April 03, 2024 | 124.98M |
| April 02, 2024 | 129.85M |
| April 01, 2024 | 129.13M |
| March 28, 2024 | 122.27M |
| March 27, 2024 | 118.48M |
| March 26, 2024 | 119.03M |
| Date | Value |
|---|---|
| March 25, 2024 | 117.40M |
| March 22, 2024 | 110.91M |
| March 21, 2024 | 106.94M |
| March 20, 2024 | 105.31M |
| March 19, 2024 | 99.90M |
| March 18, 2024 | 98.27M |
| March 15, 2024 | 96.47M |
| March 14, 2024 | 93.22M |
| March 13, 2024 | 96.65M |
| March 12, 2024 | 92.14M |
| March 11, 2024 | 94.12M |
| March 08, 2024 | 91.24M |
| March 07, 2024 | 90.69M |
| March 06, 2024 | 88.35M |
| March 05, 2024 | 90.69M |
| March 04, 2024 | 88.71M |
| March 01, 2024 | 87.81M |
| February 29, 2024 | 86.18M |
| February 28, 2024 | 91.06M |
| February 27, 2024 | 96.29M |
| February 26, 2024 | 97.19M |
| February 23, 2024 | 95.03M |
| February 22, 2024 | 95.03M |
| February 21, 2024 | 94.84M |
| February 20, 2024 | 94.84M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.35M
Minimum
Jul 02 2020
211.63M
Maximum
Jul 11 2022
83.01M
Average
87.22M
Median
Oct 18 2023
Enterprise Value Benchmarks
| Fonar Corp | 41.23M |
| XWELL Inc | -7.635M |
| Applied DNA Sciences Inc | -0.011M |
| Veracyte Inc | 1.253B |
| OncoCyte Corp | 23.78M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.751M |
| Revenue (Quarterly) | 3.499M |
| Total Expenses (Quarterly) | 14.85M |
| EPS Diluted (Quarterly) | -0.51 |
| Gross Profit Margin (Quarterly) | -87.34% |
| Profit Margin (Quarterly) | -250.1% |
| Earnings Yield | -19.03% |
| Normalized Earnings Yield | -19.03 |